Anti Human Globulin
- UID
- IMP/IVD/2020/000792_d9233f8171467de0a7a8c5a18fc195b8_8a7ccb8561402ad5cab507d6af3bb103
- Device class
- Class D
- Brand name
- NOVACLONE Anti-A Murine Monoclonal
- License holder
- Immucor India Pvt. Ltd.,
- Approving authority
- CDSCO
- Product information
- Anti-Human Globulin is used in a direct antiglobulin test (NOVACLONE Anti-A Murine Monoclonal) to detect antibodies (NOVACLONE Anti-A Murine Monoclonal) and/or complement (NOVACLONE Anti-A Murine Monoclonal) bound to human red cells in vivo. Direct antiglobulin test result may support the diagnosis of Autoimmune Hemolytic Anemia (NOVACLONE Anti-A Murine Monoclonal), Hemolytic Disease of the Newborn (NOVACLONE Anti-A Murine Monoclonal) and Delayed Hemolytic Transfusion Reactions. The indirect antiglobulin test (NOVACLONE Anti-A Murine Monoclonal) is used to detect IgG and/or complement (NOVACLONE Anti-A Murine Monoclonal) bound to human red cells in vitro and is the basis for a wide variety of immunohematology tests including tests for weak D; pre-transfusion compatibility testing (NOVACLONE Anti-A Murine Monoclonal); the detection and identification of unexpected blood group antibodies and red cells antigen typing.
Anti Human Globulin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000792_d9233f8171467de0a7a8c5a18fc195b8_8a7ccb8561402ad5cab507d6af3bb103. This device is marketed under the brand name NOVACLONE Anti-A Murine Monoclonal. The license holder is Immucor India Pvt. Ltd.,, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.